SCHAUMBURG, Ill., June 30, 2014 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America® (CTCA), in collaboration with Dannemiller, Inc. and Athena Education Group, LLC, will host a new continuing medical education (CME)* program focused on colorectal cancer and peritoneal carcinomatosis as part of its growing CME curriculum known as the CTCA Forum. The program will provide health care and oncology professionals the opportunity to learn about the latest treatment strategies and share their perspectives on the opportunities and challenges of further defining standards of care for patients with these types of cancer.
"The CTCA Forum will showcase cutting-edge research and bring together clinicians at the forefront of cancer treatment," said Jesus Esquivel, MD, FACS, Medical Director of International Oncology Initiatives and National Director for HIPEC Research at Cancer Treatment Centers of America. "We are honored to welcome this distinguished group of faculty to the CTCA Forum. By the end of the conference, we hope participants will have a stronger understanding for treating colorectal cancer and peritoneal carcinomatosis, as well as identifying patient candidates for these treatments."
Expert faculty at the CTCA Forum will present in the following order:
- David P. Ryan, MD, Chief, Hematology/Oncology, Massachusetts General Hospital, Boston, MA
Systemic Therapy in Colorectal Cancer with Peritoneal Dissemination
- H. Richard Alexander, Jr., MD, Professor of Surgery, Associate Chairman for Clinical Research, University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD
Surgical Efforts: Review of Clinical Trials
- David L. Bartlett, MD, Professor of Surgery, Chief, Division of Surgical Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA
Surgical Treatment of Liver and Lung Metastases
- Edward A. Levine, MD, Chief, Surgical Sciences-Oncology, Professor, Surgical Sciences-Oncology, Wake Forest Comprehensive Cancer Center, Winston-Salem, NC
Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Data
- John L. Marshall, MD, Director, Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Chief, Division of Hematology/Oncology, MedStar Georgetown University Hospital, Washington, DC
Molecular Profiling in Colorectal Cancer
- Maurie Markman, MD, President, Cancer Treatment Centers of America, Medicine & Science
Alternative Clinical Research Strategies: Evaluating the Utility of HIPEC in Colorectal Cancer
- Emily Chan, MD, PhD, Assistant Professor of Medicine, Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, TN
Selection Criteria for Systemic Chemotherapy and Primary Endpoints of Treatment
- Jesus Esquivel, MD, FACS, Medical Director, International Oncology Initiatives, National Director for HIPEC Research, Cancer Treatment Centers of America
Selection Criteria for CRS and HIPEC
"The future of cancer care is dependent on collaboration within the medical community to bring clinical research to the bedside quickly," said Maurie Markman, MD, President, CTCA Medicine & Science. "Through programs like this we are able to unite some of the brightest minds in cancer treatment and work together to define the future of cancer care."
The CTCA program on colorectal cancer and peritoneal carcinomatosis will be held on Friday, July 25, 2014 at the Trump International Hotel & Tower. This program offers continuing medical education credit to physicians as well as certificates documenting attendance for other types of health care providers. The CTCA Forum has been designated for a maximum of 6.0 AMA PRA Category 1 Credits™.** Registration is free to medical or surgical oncology fellows. Registrations fees for physicians are $150. For other attendees, such as nurse practitioners, physician assistants, nurses, pharmacists, naturopathic physicians, or chiropractors, registration fees are $75. To sign up for the CTCA Forum or to find additional information on conference details, visit http://www.ctcaforumcme.org.
*Dannemiller and Athena Education Group gratefully acknowledge an educational grant from Cancer Treatment Centers of America® in support of this continuing medical education activity.
**This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Dannemiller and Athena Education Group. Dannemiller is accredited by the ACCME to provide continuing medical education for physicians. Dannemiller designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the program.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America, Inc. (CTCA) is a national network of hospitals that specializes in the treatment of patients who are fighting complex or advanced-stage cancer. CTCA offers an integrative approach to cancer treatment that combines surgery, radiation, and chemotherapy with nutritional counseling, naturopathic medicine, mind-body therapy, and spiritual support to enhance quality of life and minimize side effects during treatment. The company serves patients from all fifty states at hospitals located in Atlanta, Chicago, Philadelphia, Phoenix, and Tulsa. Known for delivering the Mother Standard® of care and Patient Empowered Care®, CTCA provides patients with comprehensive information about their treatment options so they can participate in their treatment decisions. For more information about CTCA, go to www.cancercenter.com.
About Dannemiller, Inc.
Beginning in 1984, Dannemiller Inc. (Dannemiller) has grown to be a leader in continuing medical education. The company annually accredits more than 250 medical education programs and provides more than 50,000 credit hours in a variety of therapeutic categories. Today, with roots firmly planted in Anesthesiology and Pain Management, Dannemiller continues to expand its offering to a wide range of specialties in the medical community.
About Athena Education Group, LLC
Athena Education Group, LLC (Athena) is an innovative medical education company based in New Jersey which creates high-quality and unbiased educational content and programs for healthcare providers. Athena's educational programs are offered in a variety of engaging and interactive formats, including live symposia, online programs, and new media/print enduring materials. Athena has been active in the development of medical education programs in the hematology and oncology space, including for oncologists, hematologists, oncology nurses, primary care providers, and pharmacists.
SOURCE Cancer Treatment Centers of America